NDC 60687-431 Polyethylene Glycol 3350

Polyethylene Glycol 3350

NDC Product Code 60687-431

NDC 60687-431-98

Package Description: 14 POUCH in 1 CARTON > 17 g in 1 POUCH (60687-431-99)

NDC Product Information

Polyethylene Glycol 3350 with NDC 60687-431 is a a human over the counter drug product labeled by American Health Packaging. The generic name of Polyethylene Glycol 3350 is polyethylene glycol 3350. The product's dosage form is powder, for solution and is administered via oral form.

Labeler Name: American Health Packaging

Dosage Form: Powder, For Solution - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.


Polyethylene Glycol 3350 Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • POLYETHYLENE GLYCOL 3350 17 g/17g

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Oral - Administration to or by way of the mouth.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: American Health Packaging
Labeler Code: 60687
FDA Application Number: ANDA203928 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: ANDA - A product marketed under an approved Abbreviated New Drug Application. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 04-15-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Polyethylene Glycol 3350 Product Label Images

Polyethylene Glycol 3350 Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Active Ingredient (In Each Sachet)

Polyethylene Glycol 3350, NF 17g

Purpose

Laxative

Uses

  • Relieves occasional constipation (irregularity)
  • Generally produces a bowel movement in 1 to 3 days

Warnings

Allergy alert: Do not use if you are allergic to polyethylene glycol.


Do not use if you have kidney disease, except under the advice and supervision of a doctor

Ask A Doctor Before Use If You Have

  • Nausea, vomiting or abdominal pain
  • A sudden change in bowel habits that lasts over 2 weeks
  • Irritable bowel syndrome

Ask A Doctor Of Pharmacist

Before use if you are taking a prescription drug

When Using This Product

You may have loose, watery, more frequent stools

Stop Use And Ask A Doctor If

  • You have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition.
  • You get diarrhea
  • You need to use a laxative for longer than 1 week

If Pregnant Or Breast-Feeding,

Ask a health professional before use.

Keep Out Of The Reach Of Children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • Do not take more than directed unless advised by your doctor adults and children 17 years of age and older:
  • Stir and dissolve one sachet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature)
  • Drink the solution.
  • Use once a day
  • Use no more than 7 days
  • Children 16 years of age or under: ask a doctor

Other Information

  • Store at 20° - 25°C (68° - 77°F)
  • Do not use if foil is open or broken.

Inactive Ingredients

None

Package/Label Display Panel - Carton - 17 G

NDC 60687-


431-98


healthylax


®POLYETHYLENE GLYCOL 3350 NF


Powder for Oral Laxative Solution


14 SACHETS


Net Wt. 0.6 OZ (17g) EACH


Distributed by American Health Packaging, Columbus, Ohio 43217

Package/Label Display Panel – Sachet – 17 G

NDC 60687-


431-99


healthylax


®POLYETHYLENE GLYCOL 3350 NF


Powder for Oral Laxative Solution


Net Wt. 0.6 OZ (17g)Distributed by American Health Packaging, Columbus, Ohio 43217

* Please review the disclaimer below.

Previous Code
60687-430
Next Code
60687-432